questionsmedicales.fr
Phénomènes psychologiques
Processus mentaux
Perception
Perception visuelle
Perception visuelle : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Perception visuelle : Questions médicales les plus fréquentes",
"headline": "Perception visuelle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Perception visuelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-29",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Perception visuelle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Perception",
"url": "https://questionsmedicales.fr/mesh/D010465",
"about": {
"@type": "MedicalCondition",
"name": "Perception",
"code": {
"@type": "MedicalCode",
"code": "D010465",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Clignement attentionnel",
"alternateName": "Attentional Blink",
"url": "https://questionsmedicales.fr/mesh/D054518",
"about": {
"@type": "MedicalCondition",
"name": "Clignement attentionnel",
"code": {
"@type": "MedicalCode",
"code": "D054518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.145"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perception des couleurs",
"alternateName": "Color Perception",
"url": "https://questionsmedicales.fr/mesh/D003118",
"about": {
"@type": "MedicalCondition",
"name": "Perception des couleurs",
"code": {
"@type": "MedicalCode",
"code": "D003118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.217"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perception du mouvement",
"alternateName": "Motion Perception",
"url": "https://questionsmedicales.fr/mesh/D009039",
"about": {
"@type": "MedicalCondition",
"name": "Perception du mouvement",
"code": {
"@type": "MedicalCode",
"code": "D009039",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.567"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Reconnaissance visuelle des formes",
"alternateName": "Pattern Recognition, Visual",
"url": "https://questionsmedicales.fr/mesh/D010364",
"about": {
"@type": "MedicalCondition",
"name": "Reconnaissance visuelle des formes",
"code": {
"@type": "MedicalCode",
"code": "D010364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.622"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Reconnaissance faciale",
"alternateName": "Facial Recognition",
"url": "https://questionsmedicales.fr/mesh/D000066499",
"about": {
"@type": "MedicalCondition",
"name": "Reconnaissance faciale",
"code": {
"@type": "MedicalCode",
"code": "D000066499",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.622.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Clôture perceptive",
"alternateName": "Perceptual Closure",
"url": "https://questionsmedicales.fr/mesh/D010466",
"about": {
"@type": "MedicalCondition",
"name": "Clôture perceptive",
"code": {
"@type": "MedicalCode",
"code": "D010466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.677"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision binoculaire",
"alternateName": "Vision, Binocular",
"url": "https://questionsmedicales.fr/mesh/D015348",
"about": {
"@type": "MedicalCondition",
"name": "Vision binoculaire",
"code": {
"@type": "MedicalCode",
"code": "D015348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.885"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision monoculaire",
"alternateName": "Vision, Monocular",
"url": "https://questionsmedicales.fr/mesh/D015349",
"about": {
"@type": "MedicalCondition",
"name": "Vision monoculaire",
"code": {
"@type": "MedicalCode",
"code": "D015349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.893"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Perception visuelle",
"alternateName": "Visual Perception",
"code": {
"@type": "MedicalCode",
"code": "D014796",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "J Farley Norman",
"url": "https://questionsmedicales.fr/author/J%20Farley%20Norman",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychological Sciences, Ogden College of Science and Engineering, Western Kentucky University, 1906 College Heights Blvd. #22030, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu."
}
},
{
"@type": "Person",
"name": "Matan Mazor",
"url": "https://questionsmedicales.fr/author/Matan%20Mazor",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Rani Moran",
"url": "https://questionsmedicales.fr/author/Rani%20Moran",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK."
}
},
{
"@type": "Person",
"name": "Stephen M Fleming",
"url": "https://questionsmedicales.fr/author/Stephen%20M%20Fleming",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Johan Wagemans",
"url": "https://questionsmedicales.fr/author/Johan%20Wagemans",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Structure of Galectin-3 bound to a model membrane containing ganglioside GM1.",
"datePublished": "2022-08-19",
"url": "https://questionsmedicales.fr/article/35986516",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bpj.2022.08.018"
}
},
{
"@type": "ScholarlyArticle",
"name": "The prognostic role of galectin-3 and endothelial function in patients with heart failure.",
"datePublished": "2022-08-17",
"url": "https://questionsmedicales.fr/article/35975796",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5603/CJ.a2022.0074"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prognosis value of galectin-3 in patients with dilated cardiomyopathy: a meta-analysis.",
"datePublished": "2024-04-23",
"url": "https://questionsmedicales.fr/article/38680895",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.17201"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Urine Galectin-3 With Cardiorenal Outcomes in Patients With Heart Failure.",
"datePublished": "2023-06-09",
"url": "https://questionsmedicales.fr/article/37301248",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cardfail.2023.05.018"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/37175823",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24098116"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes psychologiques",
"item": "https://questionsmedicales.fr/mesh/D011579"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus mentaux",
"item": "https://questionsmedicales.fr/mesh/D008606"
},
{
"@type": "ListItem",
"position": 4,
"name": "Perception",
"item": "https://questionsmedicales.fr/mesh/D010465"
},
{
"@type": "ListItem",
"position": 5,
"name": "Perception visuelle",
"item": "https://questionsmedicales.fr/mesh/D014796"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Perception visuelle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Perception visuelle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Perception visuelle",
"description": "Comment évaluer la perception visuelle ?\nQuels examens pour troubles de la perception ?\nQuels signes indiquent un problème visuel ?\nQuand consulter un spécialiste de la vue ?\nQuelles sont les causes de troubles visuels ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Galectin+3&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Perception visuelle",
"description": "Quels symptômes de troubles de la perception ?\nComment reconnaître une illusion visuelle ?\nQu'est-ce que l'agnosie visuelle ?\nQuels signes d'une fatigue visuelle ?\nComment se manifeste la synesthésie visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Galectin+3&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Perception visuelle",
"description": "Comment prévenir les troubles de la perception ?\nQuel rôle joue l'alimentation sur la vision ?\nComment réduire la fatigue visuelle ?\nPourquoi éviter le tabac pour la vision ?\nL'exercice physique aide-t-il la vision ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Galectin+3&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Perception visuelle",
"description": "Quels traitements pour troubles de la perception ?\nComment la thérapie visuelle aide-t-elle ?\nLes lunettes corrigent-elles la perception ?\nQuand envisager une chirurgie oculaire ?\nQuels médicaments pour troubles visuels ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Galectin+3&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Perception visuelle",
"description": "Quelles complications des troubles visuels ?\nComment les troubles visuels affectent-ils la vie quotidienne ?\nQuels risques de dépression avec troubles visuels ?\nLes troubles de la perception peuvent-ils s'aggraver ?\nQuelles sont les conséquences d'une agnosie visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Galectin+3&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Perception visuelle",
"description": "Quels facteurs de risque pour troubles visuels ?\nLe diabète augmente-t-il les risques visuels ?\nComment l'hypertension affecte-t-elle la vision ?\nLe stress influence-t-il la perception visuelle ?\nLes antécédents de traumatismes oculaires sont-ils un risque ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Galectin+3&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la perception visuelle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de vision, comme l'optométrie, évaluent la perception visuelle."
}
},
{
"@type": "Question",
"name": "Quels examens pour troubles de la perception ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et l'électrorétinogramme aident à diagnostiquer les troubles de la perception."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème visuel ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés à voir, des illusions ou des distorsions visuelles peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste de la vue ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un ophtalmologiste si vous ressentez des changements soudains de vision."
}
},
{
"@type": "Question",
"name": "Quelles sont les causes de troubles visuels ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les causes incluent les maladies oculaires, les traumatismes et les troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes de troubles de la perception ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la vision floue, les halos, et les difficultés de profondeur."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une illusion visuelle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les illusions visuelles se manifestent par des perceptions erronées d'objets ou de couleurs."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'agnosie visuelle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie visuelle est l'incapacité de reconnaître des objets malgré une vision intacte."
}
},
{
"@type": "Question",
"name": "Quels signes d'une fatigue visuelle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des maux de tête, des yeux secs et une vision floue après un usage prolongé."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la synesthésie visuelle ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La synesthésie visuelle se manifeste par des associations involontaires entre couleurs et sons."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles de la perception ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Protégez vos yeux avec des lunettes de soleil et faites des examens réguliers."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation sur la vision ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en vitamines A, C et E peut aider à maintenir une bonne vision."
}
},
{
"@type": "Question",
"name": "Comment réduire la fatigue visuelle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Faites des pauses régulières lors de l'utilisation d'écrans pour réduire la fatigue visuelle."
}
},
{
"@type": "Question",
"name": "Pourquoi éviter le tabac pour la vision ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabac augmente le risque de maladies oculaires comme la dégénérescence maculaire."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il la vision ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine, bénéfique pour la santé oculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements pour troubles de la perception ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie visuelle, les lunettes et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Comment la thérapie visuelle aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie visuelle améliore la coordination œil-main et la perception visuelle."
}
},
{
"@type": "Question",
"name": "Les lunettes corrigent-elles la perception ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lunettes corrigent les erreurs de réfraction et améliorent la perception visuelle."
}
},
{
"@type": "Question",
"name": "Quand envisager une chirurgie oculaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée pour des problèmes structurels comme la cataracte ou le glaucome."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour troubles visuels ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent traiter des conditions comme le glaucome ou les infections oculaires."
}
},
{
"@type": "Question",
"name": "Quelles complications des troubles visuels ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision, l'isolement social et des troubles émotionnels."
}
},
{
"@type": "Question",
"name": "Comment les troubles visuels affectent-ils la vie quotidienne ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent limiter les activités quotidiennes, affecter le travail et la mobilité."
}
},
{
"@type": "Question",
"name": "Quels risques de dépression avec troubles visuels ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles visuels augmentent le risque de dépression en raison de l'isolement social."
}
},
{
"@type": "Question",
"name": "Les troubles de la perception peuvent-ils s'aggraver ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, certains troubles de la perception peuvent s'aggraver avec le temps."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une agnosie visuelle ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie visuelle peut entraîner des difficultés dans la reconnaissance d'objets et des interactions sociales."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour troubles visuels ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les antécédents familiaux et les maladies chroniques."
}
},
{
"@type": "Question",
"name": "Le diabète augmente-t-il les risques visuels ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut causer des complications oculaires comme la rétinopathie diabétique."
}
},
{
"@type": "Question",
"name": "Comment l'hypertension affecte-t-elle la vision ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension peut endommager les vaisseaux sanguins de l'œil, entraînant des troubles visuels."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la perception visuelle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la concentration et la clarté de la perception visuelle."
}
},
{
"@type": "Question",
"name": "Les antécédents de traumatismes oculaires sont-ils un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes oculaires augmentent le risque de troubles de la perception visuelle."
}
}
]
}
]
}
Galectin-3 (Gal-3) is a β-galactosidase-binding protein involved in various biological processes, including neuronal growth and adhesion. The pairing of Gal-3 with ganglioside GM1's pentasaccharide ch...
Heart failure (HF) is nowadays classified as HF with reduced ejection fraction (HFrEF), HF with mildly reduced EF (HFmrEF), and HF with preserved EF (HFpEF). Endothelial dysfunction (assessed by flow-...
In this study we prospectively enrolled 340 patients with stable ischemic HF. We assessed the brachial artery FMD, carotid-femoral PWV, and galectin-3 levels, and patients were followed up for MACE ac...
Interestingly, the FMD values exhibited a stepwise improvement according to left ventricular ejection fraction (LVEF) (HFrEF: 4.74 ± 2.35% vs. HFmrEF: 4.97 ± 2.81% vs. HFpEF: 5.94 ± ± 3.46%, p = 0.01)...
Flow-mediated dilatation displayed a linear improvement with LVEF in patients with ischemic HF. Deteriorated values are associated with MACE. Higher levels of galectin-3 might be used for risk stratif...
Accurate prediction and assessment of myocardial fibrosis (MF) and adverse cardiovascular events (MACEs) are crucial in patients with dilated cardiomyopathy (DCM). Several studies indicate that galect...
A comprehensive search was conducted in PubMed, EMBASE, the Cochrane Library, and Web of Science for relevant studies up to August 2023. The hazard ratios (HRs) of gal-3 for MACEs in DCM patients, and...
Seven studies, encompassing 945 patients, met the eligibility criteria. In DCM patients, abnormally elevated gal-3 levels were indicative of an increased MACEs risk (HR = 1.10, 95% CI [1.00-1.21], I...
This study's findings suggest that elevated gal-3 levels significantly correlate with increased MACE risk in DCM, highlighting its potential as a biomarker. However, significant heterogeneity among st...
CRD42023471199....
Approaches to distinguishing pathological cardiorenal dysfunction in heart failure (HF) from functional/hemodynamically mediated changes in serum creatinine are needed. We investigated urine galectin-...
We measured urine galectin-3 in 2 contemporary HF cohorts: the Yale Transitional Care Clinic (YTCC) cohort (n = 132) and the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone A...
In the YTCC cohort, there was significant effect modification between higher urine galectin-3 and lower estimated glomerular filtration rates (eGFRs) (P...
Urine galectin-3 levels correlated with an established biomarker of renal fibrosis in 2 cohorts and was able to differentiate high- vs low-risk phenotypes of chronic kidney disease in HF. These proof-...
Galectin-3 (Gal3) is one of the most studied members of the galectin family that mediate various biological processes such as growth regulation, immune function, cancer metastasis, and apoptosis. Sinc...
There are no major tools that could predict disease severity in COVID-19. The aim of this study is to evaluate if serum galectin-3 levels can identify disease progression in COVID-19....
Patients that were hospitalized due to COVID-19 between March and June 2020 were included in this cross-sectional prospective study. Baseline demographic and clinical data in addition to levels of ser...
A total of 175 patients were included in the study and among these, 64 patients formed the severe illness group whereas 111 comprised the non-severe illness group. There was statistically significant ...
In conclusion, our results indicated that galectin-3 had moderate power in outlining disease severity and the need for ICU transfer throughout the clinical course in COVID-19....
Atrial fibrillation (AF) is an irregular atrial activity and the most prevalent type of arrhythmia. Although AF is easily diagnosed with an electrocardiogram, there is a keen interest in identifying a...
Irregular sleep patterns have been associated with inflammation. Galectin-3, a novel biomarker, plays an important role in inflammation. We investigated the relationship between sleep patterns and gal...
A total of 1,058 participants from the Shenzhen-Hong Kong United Network on Cardiovascular Disease study were included in the analysis. Age and sex-adjusted linear regression models were employed to i...
Of study participants, the mean age was 45.3 years and 54.3% were women. Waist circumference, natural logarithm (ln)-transformed triglyceride, and ln-transformed high sensitivity C-reactive protein we...
Our study provides evidence of a significant association between sleep disturbance and elevated galectin-3 level, independent of traditional metabolic biomarkers. Screening and interventions on galect...
This study was to evaluate plasma galectin-3 levels from early pregnancy to delivery and explore the effects of galectin-3 on the function of trophoblast cells under high glucose exposure....
The plasma galectin-3 levels were quantified by enzyme-linked immunosorbent assay (ELISA) in the China National Birth Cohort (CNBC) at Peking University First Hospital, and the underlying signaling pa...
Significantly higher galectin-3 levels were found in patients with gestational diabetes mellitus (GDM group; n = 77) during the first and second trimesters than that in healthy pregnant women (HP grou...
Future studies were required to validate whether plasma galectin-3 might become a potential biomarker for hyperglycemia during pregnancy. Elevated galectin-3 levels might be a vital protective mechani...
Galectin-3 is a damage-associated molecular pattern (DAMPs), released from damaged or dying cells. In this study, we investigated the concentration and source of galectin-3 in the tears of patients wi...
Clinical and experimental....
We measured the concentration of galectin-3 in tear samples from 26 patients with VKC and 6 healthy controls by enzyme-linked immunosorbent assay (ELISA). The expression of galectin-3 in cultured huma...
High concentrations of galectin-3 were detected in the tears of patients with VKC. The concentration showed significant correlation with the severity of corneal epithelial damage. Stimulation of cultu...
The concentrations of galectin-3 in the tears of patients with VKC may represent a biomarker of the severity of corneal epithelial damage....